September News & Updates

News From Our Illinois Injury and Mass Tort Lawyer Blog

September 2022 News & Updates

Visit our Website

Case Updates

PACT ACT SIGNED INTO LAW

It’s official—President Biden has signed the PACT Act. The fight for justice for those harmed by contaminated water at Camp Lejeune has spanned for more than 25 years.

Camp Lejeune is a military training facility that has been recently affected by important federal law.

The water treatment facilities that supplied water to the camp from 1957-1987 were determined to be contaminated with volatile organic compounds.

Re a d More.

TYLENOL

Tylenol, also known by its generic name Acetaminophen, is an over the counter medication for high fever and pain relief.

Recently, this drug has been linked to an increase risk of autism, ADHD and other developmental disorders in children when a mother takes such drug during pregnancy.

Prior research showed that Acetaminophen was safe for pregnant women to use. However, new studies show children have a higher risk for neurological or developmental conditions when they take Tylenol or Acetaminophen.

In one study, researchers found that cord blood samples and core plasma markers of fetal exposure to Acetaminophen had a higher ADHD diagnosis risk.

Follow Our Instagram!

From Our Illinois Injury and Mass Tort Lawyer Blog

Banana Boat Hair and Scalp Sunscreen Spray Recalled

Banana Boat sunscreen has recalled several batches of its hair and scalp sunscreen sprays. The sprays were found to contain trace amounts of Benzene, a cancer causing chemical.

The Centers for Disease Control and Prevention has told the public that the blood and bone marrow may be affected, and long term exposure to benzene can lead to cancer. Benzene exposure could occur by ingestion, inhalation or through your skin.

Accordingly, the manufacturer has asked consumers to stop using the affected sunscreen and throw it out. You can be reimbursed if you purchased the recalled products. However, this doesn’t help you if you were injured or otherwise harmed by the sunscreen spray.

Early in July, Mylan Pharmaceuticals, Inc. voluntarily recalled a batch of its prefilled Insulin Glargine Injection pens that come in 100 units/mL, 3 mL. The pens include an insulin analog that is long-acting. Doctors prescribe it for glycemic controls in both adults and children who have type 1 or type diabetes.

The pens in questions are packed five pens to a carton and sold to patients with diabetes. The carton includes information about the product, batch number, and the date the pens expire. The manufacturer recalled a batch that omitted a label on certain pens. Due to this lack of labeling, a patient could mix up the products and strengths of the unbranded pens. This, in turn, could lead to insufficient glycemic control, and either excessively high or low blood sugar.